138 results on '"Juhász, E."'
Search Results
2. A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer
3. Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)
4. A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC)
5. Cardiac surgery in the elderly: impact on hospital management and economics
6. Significance and Imaging of Lumbar Veins and Early-Branching Arteries in Planning Living-Donor Laparoscopic Nephrectomy: Two Case Reports From 21 Months' Experience
7. Phase I/II Study of a 3 Weekly Oral Taxane (DJ-927) in Patients with Recurrent, Advanced Non-small Cell Lung Cancer
8. Plasma lipoprotein(a) concentration and phenotypes in diabetes mellitus
9. Systematic Investigation of Sodium Alkylsulphate Micelles Using Small Angle Neutron Scattering and Positron Annihilation Techniques
10. Recommended Reference Materials for Realization of Physicochemical Properties. Section: Electrolytic Conductivity
11. PMU85 - CONSUMER SURVEY OF HEALTH AND RECREATIONAL TOURISM IN THE WEST-TRANSDANUBIAN REGION OF HUNGARY
12. Target: a Randomized, Phase Ii Trial Comparing Vintafolide Versus Vintafolide Plus Docetaxel, Versus Docetaxel Alone in Second-Line Treatment of Folate-Receptor-Positive Non-Small Cell Lung Cancer (Nsclc) Patients
13. 1426PD - Phase II study of roniciclib in combination with cisplatin/etoposide or carboplatin/etoposide as first-line therapy in subjects with extensive-disease small cell lung cancer (ED-SCLC)
14. Effects of microwave heating on native and resistant starches
15. 3091 Characterization of advanced NSCLC patients with prolonged benefit after veliparib plus carboplatin/paclitaxel: Phase 2 results
16. 3093 Veliparib with carboplatin and paclitaxel: factors predictive of favorable outcomes in NSCLC
17. 102PD - A Randomized, Double-Blind, Phase 2 Trial of Veliparib (ABT-888) with Carboplatin and Paclitaxel in Previously Untreated Metastatic or Advanced Non-Small Cell Lung Cancer
18. PCN132 ERLOTINIB MAINTENANCE THERAPY FOR NON-SMALL CELL LUNG CANCER PRESERVES QUALITY OF LIFE
19. A randomized phase II study of paclitaxel (P) and carboplatin (C) ± bevacizumab (B) ± dulanermin (D) in non-small cell lung cancer (NSCLC).
20. Alterations of Carbohydrate and Lipoprotein Metabolism in Childhood Obesity - Impact of Insulin Resistance and Acanthosis Nigricans
21. Value of esophageal impedance monitoring in clinical diagnostics
22. Interim evaluation of our experience with infliximab treatment in IBD
23. A phase II study of DJ-927 administered orally once every three weeks as second line therapy to subjects with locally advanced or metastatic non small cell lung cancer (NSCLC) after failure of platinum-based non-taxane regimen
24. LBA40_PR - Target: a Randomized, Phase Ii Trial Comparing Vintafolide Versus Vintafolide Plus Docetaxel, Versus Docetaxel Alone in Second-Line Treatment of Folate-Receptor-Positive Non-Small Cell Lung Cancer (Nsclc) Patients
25. 1234P - A Randomized, Double-Blind, Phase 2 Trial of Veliparib (Abt-888) with Carboplatin and Paclitaxel in Previously Untreated Metastatic or Advanced Non-Small Cell Lung Cancer
26. Clinical experiences with clodronate in metastatic bone disease
27. Late Neogene sedimentary facies and sequences in the Pannonian Basin, Hungary
28. Climatically driven sedimentary cycles in the Late Miocene sediments of the Pannonian Basin, Hungary
29. High lipoprotein(a) levels with predominance of high molecular weight apo(a) isoforms in patients with pulmonary embolism
30. Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non-Small-Cell Lung Cancer.
31. LBA9_PR - Association Between Tumor Egfr and Kras Mutation Status and Clinical Outcomes in Nsclc Patients Randomized to Sorafenib Plus Best Supportive Care (BSC) or Bsc Alone: Subanalysis of the Phase III Mission Trial
32. 1239P - Clinical Genotyping and Efficacy Outcomes: Exploratory Biomarker Data from the Phase II Abigail Study of 1st-Line Bevacizumab + Chemotherapy in Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC)
33. 1236PD - Tumour Biomarker and Plasma Time Course Data from Abigail, A Phase II Study of 1st-Line Bevacizumab + Chemotherapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC)
34. PREPARATION OF RAW MATERIALS FOR FINE CERAMICS IN PLASMAS
35. 9307 POSTER Oncogenic Mutation Dependent Response to Growth Factors in Melanoma Cells
36. 9003 ORAL Biomarker Analysis in BO21015, a Phase II Randomised Study of First-line Bevacizumab (BEV) Combined With Carboplatin-gemcitabine (CG) or Carboplatin-paclitaxel (CP) in Patients (pts) With Advanced or Recurrent Non-squamous Non-small Cell Lung Cancer (NSCLC)
37. 1203 ORAL Long-term Survival in a Phase II Study of Belagenpumatucel-L (TGF-β Antisense Modified Tumour Cell Vaccine) in Non-small Cell Lung Cancer (NSCLC)
38. Two hundred million years of karst history, Dachstein Limestone, Hungary.
39. Reizen HvJ 6 mei 2010 Zaak C-63/09 (Walz/Clickair) - aansprakelijkheid luchtvervoerder - Verordening (EG) nr. 889/2002 - Verdrag van Montreal 1999 - schadebegrip - materiële/immateriële schade.
40. Jurisprudentie Nr. 2* Circus Globus Hof van Justitie van de Europese Unie 24 november 2011 zaaknr. C-283/10 Artikel 3 lid 1 van de Auteursrichtlijn betreft uitsluitend de mededeling aan het publiek dat niet aanwezig is op de plaats van oorsprong van...
41. The role of certified reference materials in metrology
42. Use of asymmetrically-polarised dropping-mercury electrodes in controlled-potential polarography
43. Durch einen Rinderleberextrakt hervorgerufene Eosinopenie bei nebennierenlosen Ratten
44. Über die isolierung eines in den weissen blutkörperchen (eosinophilen leukozyten) nachgewiesenen “natürlichen antihistamins”
45. Coagulase-negative staphylococcal endophthalmitis: clinical severity and outcomes based on speciation.
46. Three major steps toward the conservation of freshwater and riparian biodiversity.
47. Prevalence, serogroup distribution and risk factors of Neisseria meningitidis carriage in high school and university students in Hungary.
48. Molecular microbiological testing of lower respiratory tract samples during COVID-19 pandemic
49. Foraging decisions with conservation consequences: Interaction between beavers and invasive tree species.
50. The Medicago truncatula IEF Gene Is Crucial for the Progression of Bacterial Infection During Symbiosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.